Purchase Order 75N93020P00263

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 4,562,626,703 units of the drug Glyburide-Metformin 2.5-500 mg, with a potential value of $1,452.32. The order has an anticipated completion date of October 30, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has...

This federal contract award is for the delivery of Glyburide-Metformin 5-500 mg, 100 count, to the Defense Logistics Agency (DLA). The contract, valued at $1,053.52, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor...

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and a ceiling value of $2,155.92. It is not designated as a set-aside contract. The contract provides for the delivery of GLYBURIDE-METFORMIN 5-500 MG 100S, a pharmaceutical product used for the treatment of diabetes. This Delivery Order is part of a larger...

This federal contract award, with ID SPE2DB20D1100|SPE2DB24FA1H3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $26,011.67 and an ultimate completion date of February 8, 2024. The contract is for the supply of 4563588613 - GLYBURIDE 5 MG TABLET 1000S, a medical product used for the management of diabetes. This...

This federal contract award, with an ID of SPE2DB20D3103|SPE2DB22FM7H0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glucagen 1 mg hypokits, a critical medical product used in the treatment of hypoglycemia. The contract has a ceiling value of $1,287.90 and a completion date of February 24, 2022. It is a delivery order contract with a firm fixed price pricing type. The...

Defense Logistics Agency awarded a $37 firm fixed price delivery order to Amerisourcebergen Drug Corporation, located in Conshohocken, Pennsylvania, for 100 tablets of 4 mg Glimepiride to be delivered by October 10, 2023. The order was placed under an existing contract vehicle on October 6, 2023, with no set-aside designation specified. Amerisourcebergen will fulfill the order for the generic oral hypoglycemic medication to support the Defense Logistics Agency's medical supply chain programs.

This is a firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS), to American Biochemicals Inc. The contract is for the provision of 1 gram of ML246 (metarrestin) compound for $86,000.00. The contract does not have a set-aside designation. American Biochemicals Inc. is a minority-owned, small disadvantaged business that specializes in small molecule design, optimization,...

The Defense Logistics Agency Troop Support Medical awarded a $246 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 10 mg Glipizide. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is August 1-2, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order for the generic oral hypoglycemic medication in support of DLA...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,772,073 units of Glucagon 1 mg vials, a critical medication used to treat severe hypoglycemia. The contract has a firm fixed price of $13,645.48 and a performance period ending on September 13, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has significant experience supplying pharmaceutical and medical...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Government Scientific Source Inc. (GSS), a for-profit business, to provide 4,566,665,297 units of liquid diabetes medication (6 x 1 ml). The contract has a total ceiling value of $12,406.80 and is a fixed-price contract with economic price adjustment. The period of performance runs through December 31, 2024. This contract was not set aside for small businesses. As a prime contractor, GSS has...